ArticleVirology journal2025
Lamin A/C promotes HBV transcription by modulating histone modification associated with cccDNA minichromosome in an HBx-dependent manner.
Article in Virology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundChronic hepatitis B virus (HBV) infection remains a serious public health challenge, and primary treatment strategies are unable to cure HBV infection due to the persistence of HBV covalently closed circular DNA (cccDNA) in the nuclei of cells. The HBV X protein (HBx) plays a crucial role in regulating cccDNA transcription. Therefore, targeting HBx to identify host proteins that regulate cccDNA transcription could represent a curative approach.
methodsHere, we used co-immunoprecipitation (co-IP) and mass spectrometry (MS) to identify proteins that interact with HBx. The candidate proteins Lamin A and C (Lamin A/C) were knocked down by RNA interference, and Lamin A/C was overexpressed via lentiviral vectors in HBV-infected cell cultures. Chromatin immunoprecipitation (ChIP) followed by quantitative PCR (ChIP-qPCR) was used to investigate protein-DNA interactions.
resultsA mechanistic study revealed that Lamin A/C bound to HBx, resulting in reduced degradation of HBx by the 26S proteasome. Moreover, Lamin A/C regulated HBV cccDNA transcription in vitro, which was associated with HBx. In addition, Lamin A/C knockdown resulted in transcriptional silencing of the HBV cccDNA but not in HBV-HBx-deficient (∆HBx)-infected cells. Importantly, experimental knockdown of Lamin A/C reduced the level of active histone modifications (H3K4me3 and H3k27Ac) bound to cccDNA and increased the level of inhibited histone modifications (H3K9me3 and H3K27me3) bound to cccDNA, which was suppressed in the HBV-∆HBx system.
conclusionOur findings reveal that Lamin A/C acts as a new host factor for HBV cccDNA through an epigenetic regulatory mechanism that can interact with HBx and prevent its degradation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.